Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 10/20 | 0.81 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.63 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.63 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.63 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27456705 | 0.98 | SIGMAR1 (0.77) | SIGMAR1S1PR2S1PR4S1PR1S1PR3 | |
| SCHEMBL8034862 | 0.92 | SIGMAR1 (0.75) | SIGMAR1 | |
| SCHEMBL7360959 | 0.92 | SIGMAR1 (0.81) | SIGMAR1S1PR2S1PR4S1PR1S1PR3 | |
| SCHEMBL7296296 | 0.92 | SIGMAR1 (0.81) | SIGMAR1S1PR2S1PR4S1PR1S1PR3 | |
| SCHEMBL3681105 | 0.92 | SIGMAR1 (0.79) | SIGMAR1 | |
| Hydrochloric Acid SCHEMBL6895156 | 0.90 | SIGMAR1 (0.76) | SIGMAR1 | |
| SCHEMBL4819795 | 0.90 | SIGMAR1 (0.77) | SIGMAR1S1PR2S1PR4S1PR1S1PR3 | |
| SCHEMBL26985759 | 0.90 | SIGMAR1 (0.77) | SIGMAR1S1PR2S1PR4S1PR1S1PR3 | |
| SCHEMBL30045011 | 0.90 | SIGMAR1 (0.66) | SIGMAR1S1PR2S1PR4S1PR1S1PR3 | |
| SCHEMBL9819830 | 0.90 | SIGMAR1 (1.00) | SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2498746-B1 | SKIN CARE COMPOSITIONS COMPRISING PHENOXYALKYL AMINES | UNILEVER PLC NO 41424 (GB) | 2016-08-24 | — | — | EP | disclosed |
| EP-2498746-B1 | SKIN CARE COMPOSITIONS COMPRISING PHENOXYALKYL AMINES | UNILEVER PLC NO 41424 (GB) | 2016-08-24 | — | — | EP | disclosed |
| US-8309064-B2 | Skin care compositions comprising phenoxyalkyl amines | CONOPCO, INC. (US) | 2012-11-13 | — | — | US | disclosed |
| US-8309064-B2 | Skin care compositions comprising phenoxyalkyl amines | CONOPCO, INC. (US) | 2012-11-13 | — | — | US | disclosed |
| US-8309064-B2 | Skin care compositions comprising phenoxyalkyl amines | CONOPCO, INC. (US) | 2012-11-13 | — | — | US | disclosed |
| WO-2011054804-A2 | SKIN CARE COMPOSITIONS COMPRISING PHENOXYALKYL AMINES | UNILEVER PLC (GB) | 2011-05-12 | — | — | WO | disclosed |
| US-20110110870-A1 | SKIN CARE COMPOSITIONS COMPRISING PHENOXYALKYL AMINES | CONOPCO, INC., D/B/A UNILEVER (US) | 2011-05-12 | — | — | US | disclosed |
| US-20110110870-A1 | SKIN CARE COMPOSITIONS COMPRISING PHENOXYALKYL AMINES | CONOPCO, INC., D/B/A UNILEVER (US) | 2011-05-12 | — | — | US | disclosed |
| US-20110110870-A1 | SKIN CARE COMPOSITIONS COMPRISING PHENOXYALKYL AMINES | CONOPCO, INC., D/B/A UNILEVER (US) | 2011-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110110870-A1 | SKIN CARE COMPOSITIONS COMPRISING PHENOXYALKYL AMINES | CUTA, TYR, FLNA | SIGMAR1 2642/4885S1PR2 2188/4885S1PR4 1988/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.